<SEC-DOCUMENT>0001144204-16-079141.txt : 20160205
<SEC-HEADER>0001144204-16-079141.hdr.sgml : 20160205
<ACCEPTANCE-DATETIME>20160205074751
ACCESSION NUMBER:		0001144204-16-079141
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160205
FILED AS OF DATE:		20160205
DATE AS OF CHANGE:		20160205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dehaier Medical Systems Ltd
		CENTRAL INDEX KEY:			0001474627
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34661
		FILM NUMBER:		161390192

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 501, JIUZHOU PLAZA
		STREET 2:		83 FUXING ROAD,
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100856
		BUSINESS PHONE:		(8610) 5166-0080

	MAIL ADDRESS:	
		STREET 1:		SUITE 501, JIUZHOU PLAZA
		STREET 2:		83 FUXING ROAD,
		CITY:			HAIDIAN DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100856
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v430701_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>U.S. SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the month of February 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Commission File Number: 001-34661</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>DEHAIER MEDICAL SYSTEMS LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Dehaier Medical Systems Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Room 501, 83 Fuxing Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Haidian District, Beijing 100856</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Address of principal executive offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">Form 20-F&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT></FONT></TD>
    <TD STYLE="width: 50%; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">Form 40-F&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Explanatory Note:</U></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Registrant today announced its corporate
and business restructuring plan which aims to concentrate the Registrant&rsquo;s resources to develop its mobile health business,
including wearable sleep respiratory business and to focus more on its major businesses. As of this announcement, the Registrant
has officially launched the business and corporate restructuring process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The business and corporate restructuring
process includes, but not limited to: (1) setting up a wholly owned subsidiary, Connection Wearable Health Technology (Beijing)
Co., Ltd. (&ldquo;CWHT&rdquo;), in Beijing, to conduct wearable sleep respiratory and mobile health related businesses; (2) continuing
scaling down and discontinuing, as appropriate, its unprofitable medical device business and maintaining only a few profitable
businesses such as sales of its patented medical air compressors and cardiopulmonary resuscitation (&ldquo;CPR&rdquo;) instruments
in the future; and (3) completing an acquisition of 0.8% equity interest of Beijing Dehaier Medical Technology Co., Ltd. (&ldquo;BDL&rdquo;)
from Beijing Dehaier Technology Co., Ltd. (&ldquo;BTL&rdquo;) on January 14, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">The following document is filed herewith:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="width: 10%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number</B></P></TD>
    <TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font-weight: bold; font-size: 10pt; text-align: center; width: 88%"><FONT STYLE="font-size: 10pt"><B>Document</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Press Release dated February 5, 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 48pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold"><FONT STYLE="font-size: 10pt"><B>DEHAIER MEDICAL SYSTEMS LIMITED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">February 5, 2016</FONT></TD>
    <TD NOWRAP><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">/s/ Ping Chen</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Ping Chen</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Chief Executive Officer</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Principal Executive Officer) and</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Duly Authorized Officer</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v430701_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 80px; width: 226px"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Dehaier Medical Announces Corporate Restructuring
Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>BEIJING, February 5, 2016 - </B>Dehaier
Medical Systems Ltd. (Nasdaq: DHRM) (&quot;Dehaier Medical&quot; or the &quot;Company&quot;), which develops, markets and sells
medical devices and wearable sleep respiratory products in China and international markets, today announced its corporate and business
restructuring plan which aims to concentrate the Company&rsquo;s resources to develop its mobile health business, including wearable
sleep respiratory business and to focus more on its major businesses. As of this announcement, the Company has officially launched
the business and corporate restructuring process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the restructuring, the Board
of Directors of the Company directed the Company to set up a wholly owned subsidiary, Connection Wearable Health Technology (Beijing)
Co., Ltd. (&ldquo;CWHT&rdquo;), in Beijing. The Company is conducting related procedures to establish CWHT and it anticipates the
process to be completed by the end of February 2016. After its incorporation, CWHT will conduct wearable sleep respiratory and
mobile health related businesses. On the other hand, BDL will focus on remaining profitable medical device sales, collection of
existing accounts receivable, selling off remaining inventory, management and maintenance of intellectual property assets and certifications
of all subsidiaries of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expects to continue scaling
down and discontinuing, as appropriate, its unprofitable medical device business, including assembly and sales of X-ray machines
and anesthesia machines. The Company plans to maintain only a few profitable businesses such as sales of its patented medical air
compressors and cardiopulmonary resuscitation (&ldquo;CPR&rdquo;) instruments in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 14, 2016, the Company completed
an acquisition of 0.8% equity interest of Beijing Dehaier Medical Technology Co., Ltd. (&ldquo;BDL&rdquo;) from Beijing Dehaier
Technology Co., Ltd. (&ldquo;BTL&rdquo;). The Company now holds 100% of the equity interest of BDL. This change reflects BTL&rsquo;s
reduced reliance on business with BDL in providing repair and maintenance services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Ping Chen, CEO of the Company commented
to the restructuring plan, &ldquo;We believe these changes are crucial to improve our competitiveness over the longer term. By
restructuring our Company to reduce our reliance on our less profitable medical devices assembly and distribution businesses, we
will be more able to leverage our resources to develop smart health products and services, which we see as the future of our Company.
Our long-term goal is to gradually decrease our production business, and focus instead on developing a complete mobile health operation
platform as well as a supply chain management platform by utilizing the products produced by third parties. &rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.05pt 0pt 0; text-align: justify"><B>About Dehaier Medical Systems
Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dehaier Medical is an emerging leader in
the development, marketing and sale of medical products, including medical devices and wearable sleep respiratory products in China
and international markets. The company develops and assembles its self-branded medical devices and sleep respiratory products from
third-party components. The company also distributes products designed and manufactured by other companies, including medical devices
from HEYER (Germany) and Timesco (UK). Dehaier Medical&rsquo;s technology is based on six patents and eleven software copyrights.
More information may be found at http://www.dehaier.com.cn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>Forward-looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>This news release contains forward-looking
statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning
plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other
than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product
and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of
competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and
Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company,
are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances
after the date hereof.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>For more information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Dehaier Medical Systems Limited</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Janice Wang</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">+86 10-5166-0080 ext. 211</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">investors@dehaier.com.cn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 .(# 2(  A$! Q$!_\0
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MPJ)/B9U655^Z&4$ @8Z$5@;HR+KQY)I6A^&Y;RS274=8C4A1(8XT.T%F)P2
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MQ*0 0"I!YP/>MRWB2WMXX4+;8U"C<Q8X QR3R?J>M F6****8!1110 4444
M(0#U%,\J,$'8,C&#CTSC^9_.I**+@%)@$8-+10!333X(Y3)&GED\LJ@!6],C
MH2/7K[U<HHHN^HD%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
-** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
